{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:46:51Z","timestamp":1780667211325,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijid.2024.106989","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T16:43:56Z","timestamp":1709138636000},"page":"106989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparative effectiveness of empirical antibiotic treatments in methicillin-susceptible Staphylococcus aureus infective endocarditis: A post hoc analysis of a prospective French cohort study"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2144-9221","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Lecomte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1133-5207","authenticated-orcid":false,"given":"Colin","family":"Deschanvres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Bourreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Ruffier d'Epenoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Le Turnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gaborit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0110-9054","authenticated-orcid":false,"given":"Thierry","family":"Le Tourneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5892-2946","authenticated-orcid":false,"given":"Pascale","family":"B\u00e9mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Corvec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.106989_bib0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s13054-019-2632-1","article-title":"Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia","volume":"23","author":"Lee","year":"2019","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.ijid.2024.106989_bib0002","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","article-title":"Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study","volume":"40","author":"Habib","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijid.2024.106989_bib0003","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/cis199","article-title":"Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey","volume":"54","author":"Selton-Suty","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0004","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijid.2024.106989_bib0005","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijid.2024.106989_bib0006","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijid.2024.106989_bib0007","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cmi.2020.08.044","article-title":"Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study","volume":"27","author":"Lecomte","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2024.106989_bib0008","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cid\/cix287","article-title":"Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study","volume":"65","author":"McDanel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0009","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/cid\/cir857","article-title":"A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus","volume":"54","author":"Wieland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0010","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","article-title":"Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","volume":"17","author":"Paul","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2024.106989_bib0011","first-page":"375","article-title":"Effectiveness and safety of ceftriaxone compared to standard of care for treatment of bloodstream infections due to methicillin-susceptible Staphylococcus aureus: a systematic review and meta-analysis","volume":"11","author":"Alsowaida","year":"2022","journal-title":"Antibiot Basel Switz"},{"key":"10.1016\/j.ijid.2024.106989_bib0012","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s11096-014-9999-5","article-title":"Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible Staphylococcal aureus (MSSA) bloodstream infections","volume":"36","author":"Patel","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.ijid.2024.106989_bib0013","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/jac\/dkac152","article-title":"Empirical use of \u03b2-lactam\/\u03b2-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study","volume":"77","author":"Willekens","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.106989_bib0014","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/jac\/dkad057","article-title":"Comparative effectiveness of \u03b2-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study","volume":"78","author":"Buis","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.106989_bib0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10096-023-04575-z","article-title":"Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia","volume":"42","author":"Yetmar","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106632","article-title":"Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia","volume":"60","author":"Mohamed","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2024.106989_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01530-21","article-title":"Comparable effectiveness of cefuroxime and piperacillin-tazobactam as empirical therapy for methicillin-susceptible Staphylococcus aureus bacteremia","volume":"10","author":"Bigseth","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijid.2024.106989_bib0018","doi-asserted-by":"crossref","first-page":"ofz270","DOI":"10.1093\/ofid\/ofz270","article-title":"Comparative effectiveness of exclusive exposure to nafcillin or oxacillin, cefazolin, piperacillin\/tazobactam, and fluoroquinolones among a national cohort of veterans with methicillin-susceptible Staphylococcus aureus bloodstream infection","volume":"6","author":"Beganovic","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167112","article-title":"Comparable effectiveness of first week treatment with anti-staphylococcal penicillin versus cephalosporin in methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study","volume":"11","author":"Forsblom","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijid.2024.106989_bib0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dkt375","article-title":"Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study","volume":"69","author":"Rasmussen","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.106989_bib0021","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC Guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijid.2024.106989_bib0022","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/cid\/ciz014","article-title":"Risk-benefit assessment of systematic thoracoabdominal-pelvic computed tomography in infective endocarditis","volume":"69","author":"Lecomte","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0023","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/cid\/ciz1177","article-title":"Long-term outcome of patients with nonoperated prosthetic valve infective endocarditis: is relapse the main issue?","volume":"71","author":"Lecomte","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0024","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0025","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/eurheartj\/ehs379","article-title":"Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis","volume":"34","author":"L\u00f3pez","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijid.2024.106989_bib0026","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/civ308","article-title":"Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals","volume":"61","author":"McDanel","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0027","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2334-11-279","article-title":"Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"11","author":"Schweizer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0028","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jac\/dkg440","article-title":"Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis","volume":"52","author":"Drinkovi\u0107","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.106989_bib0029","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.106989_bib0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2024.106989_bib0031","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-125-12-199612150-00005","article-title":"Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial","volume":"125","author":"Ribera","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2024.106989_bib0032","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07853890.2016.1235282","article-title":"Time interval between infective endocarditis first symptoms and diagnosis: relationship to infective endocarditis characteristics, microorganisms and prognosis","volume":"49","author":"N'Guyen","year":"2017","journal-title":"Ann Med"},{"key":"10.1016\/j.ijid.2024.106989_bib0033","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/cid\/ciz027","article-title":"Outpatient parenteral antibiotic treatment for infective endocarditis: insights from real life","volume":"69","author":"Tattevin","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T11:05:05Z","timestamp":1723201505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224000602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"alternative-id":["S1201971224000602"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.106989","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of empirical antibiotic treatments in methicillin-susceptible Staphylococcus aureus infective endocarditis: A post hoc analysis of a prospective French cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.106989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"106989"}}